medigraphic.com
ISSN 2007-8013 (Print)
Órgano oficial de la Universidad Autónoma de Sinaloa

2022, Number 1

<< Back Next >>

Rev Med UAS 2022; 12 (1)

Environmental Cofactors Associated with the Development of Cervical Intraepithelial Neoplasia and Cervical Cancer

Medina-de la Cruz O, Villegas-Hinojosa E, Ruíz-Baca E, Gallegos-García V

Language: Spanish
References: 71
Page: 56-69
PDF size: 341.94 Kb.


ABSTRACT

Cervical Cancer (CC) is one of the main causes of morbidity and mortality worldwide and in Mexico. This disease requires the presence of the Human Papilloma Virus (HPV) for its progress to Cervical Intraepithelial Neoplasia (CIN), but in addition to other co-factors. Among these, environmental or exogenous cofactors, those of the viral, host or intrinsic and those of the social type have been proposed. This review addresses those of an environmental nature, among them are: the use of oral hormonal contraceptives, smoking, exposure to biomass smoke, diet, cervical trauma, Early Sexual Life Onset (IVSET), multiple sexual partners, co-infection with other sexually transmitted diseases, non-use of condoms and circumcision of the couple. The co-factors modulate the progress of the different grades of CIN to CC, therefore it is important to know them and analyze how the influence the appearance of this pathology.


REFERENCES

  1. Bray F, Ferlay J, Soerjomataram I, SiegelRL, Torre LA, Jemal A. Global cancerstatistics 2018: GLOBOCAN estimates ofincidence and mortality worldwide for 36cancers in 185 countries. CA Cancer J Clin 2018;68(6):394-424.

  2. Lin L, Yan L, Liu Y, Yuan F, Li H, Ni J.Incidence and death in 29 cancer groups in2017 and trend analysis from 1990 to 2017from the Global Burden of Disease Study. JHematol Oncol 2019;12(1):96.

  3. World Health O. Global health Observatory,2018. Geneva: health organization[Online],Available: who int/gho/database/en.

  4. Hernández-Hernández DM, Apresa-GarcíaT, Patlán-Pérez RM. Epidemiologicaloverview of uterine cervical cancer. Rev MedInst Mex Seguro Soc. 2015;53(S2):154-61.

  5. Castellsagué X, Munoz N. Chapter 3:Cofactors in human papillomaviruscarcinogenesis—role of parity, oralcontraceptives, and tobacco smoking. JNCIMonograp 2003;2003(31):20-8.

  6. Loopik DL, IntHout J, Melchers WJG,Massuger LFAG, Bekkers RLM, Siebers AG.Oral contraceptive and intrauterine deviceuse and the risk of cervical intraepithelialneoplasia grade III or worse: a populationbasedstudy. Eur J Cancer 2020;124:102-9.

  7. Ferrera A, Velema JP, Figueroa M, BulnesR, Toro LA, Claros JM, et al. Co-factorsrelated to the causal relationship betweenhuman papillomavirus and invasive cervicalcancer in Honduras. Int J Epidemiol2000;29(5):817-25.

  8. Barchitta M, Maugeri A, La Mastra C, RosaMCL, Favara G, Lio RMS, et al. DietaryAntioxidant Intake and HumanPapillomavirus Infection: Evidence from aCross-Sectional Study in Italy. Nutrients2020;12(5):1384.

  9. Morris BJ, Gray RH, Castellsague X, BoschFX, Halperin DT, Waskett JH, et al. Thestrong protective effect of circumcisionagainst cancer of the penis. Adv Urol2011;2011.

  10. Ibrahim A, Rasch V, Pukkala E, Aro AR.Cervical cancer risk factors and feasibility ofvisual inspection with acetic acid screeningin Sudan. Int J Women's Health 2011;3:117.

  11. Kashyap N, Krishnan N, Kaur S, Ghai S.Risk Factors of Cervical Cancer: A Case-Control Study. Asia Pac J Oncol Nurs2019;6(3):308.

  12. Sierra􀇦Torres CH, Arboleda􀇦Moreno YY,Orejuela􀇦Aristizabal L. Exposure to woodsmoke, HPV infection, and geneticsusceptibility for cervical neoplasia amongwomen in Colombia. Environ Mol Mutagen2006;47(7):553-61.

  13. Chih HJ, Lee AH, Colville L, Xu D, Binns CW.Condom and oral contraceptive use and riskof cervical intraepithelial neoplasia inAustralian women. J Gynecol Oncol2014;25(3):183-7.

  14. Grevers X, Grundy A, Poirier AE, KhandwalaF, Feldman M, Friedenreich CM, et al.Cancer incidence attributable to the use oforal contraceptives and hormone therapy inAlberta in 2012. CMAJ Open2016;4(4):E754.

  15. Moreno V, Bosch FX, Muñoz N, MeijerCJLM, Shah KV, Walboomers JMM, et al.Effect of oral contraceptives on risk ofcervical cancer in women with humanpapillomavirus infection: the IARCmulticentric case-control study. Lancet2002;359(9312):1085-92.

  16. Chung S-H. Targeting female hormonereceptors as cervical cancer therapy. TrendsEndocrinol Metab 2015;26(8):399-401.

  17. Chung S-H, Franceschi S, Lambert PF.Estrogen and ERα: Culprits in cervicalcancer?. Trends Endocrinol Metab2010;21(8):504-11.

  18. Shew ML, McGlennen R, Zaidi N,Westerheim M, Ireland M, Anderson S.Oestrogen receptor transcripts associatedwith cervical human papillomavirus infection.Sex Transmit Infec 2002;78(3):210-4.

  19. Gao T, Wang J, Yang M, Li H. Transcriptomeanalysis reveals the effect of oralcontraceptive use on cervical cancer. MolMed Rep 2014;10(4):1703-8.

  20. Haverkos HW. Viruses, chemicals and cocarcinogenesis.Oncogene2004;23(38):6492-9.

  21. Haverkos HW, Haverkos GP, O’Mara M. Cocarcinogenesis:human papillomaviruses,coal tar derivatives, and squamous cellcervical cancer. Front Microbiol2017;8:2253.

  22. Wei L, Griego AM, Chu M, Ozbun MA.Tobacco exposure results in increased E6and E7 oncogene expression, DNA damageand mutation rates in cells maintainingepisomal human papillomavirus 16genomes. Carcinog 2014;35(10):2373-81.

  23. Baltazar-Rodriguez LM, Anaya-Ventura A,Andrade-Soto M, Monrroy-Guizar EA,Bautista-Lam JR, Jonguitud-Olguin G, et al.Polymorphism in the matrixmetalloproteinase-2 gene promoter isassociated with cervical neoplasm risk inMexican women. Bioch Genet 2008;46(3-4):137-44.

  24. Morales Vargas R. Contaminación del aire yefectos tóxicos por partículas respirables(PM10) en el humo, de madera encomercios de alimentos San José-CostaRica. Rev Cost Sal Púb 2003;12(22):16-28.

  25. Yeganeh Z, Sheikhan Z, Kariman N, EstekiT, Dolatian M, Mahmoodi Z, et al. Lifestyleand nutritional risk in women with cervicalcancer: A comparative study. Int J FertilWomens Med 2019;7(4):501-7.

  26. Medina de la Cruz O, Villegas-Hinojosa E,Gaytán-Hernández D, Gutiérrez-EnríquezSO, Gallegos-García V. Identificación decofactores nutricionales asociados aneoplasia intraepitelial cervical en mujeresde San Luis Potosí. Tequio 2018; 4 (1):37-47.

  27. Hwang JH, Lee JK, Kim TJ, Kim MK. Theassociation between fruit and vegetableconsumption and HPV viral load in high-riskHPV-positive women with cervicalintraepithelial neoplasia. Cancer CausesControl 2010;21(1):51-9.

  28. Labani L, Andallu B, Meera M, Asthana S,Satyanarayana L. Food consumption patternin cervical carcinoma patients and controls.Indian J Med Paediatr Oncol 2009;30(2):71.

  29. Acevedo OG, Ugalde PZ, García VG, deLeón Martínez LD, Hernández DG. Ingestade antioxidantes y su asociación a CáncerCervicouterino en mujeres de un SistemaUniversitario. RESPYN Rev Sal Pub Nut2020;19(1):23-32.

  30. Guo L, Zhu H, Lin C, Che J, Tian X, Han S,et al. Associations between antioxidantvitamins and the risk of invasive cervicalcancer in Chinese women: A case-controlstudy. Scient Rep 2015;5:13607.

  31. Koshiyama M, Nakagawa M, Ono A. ThePreventive Effect of Dietary AntioxidantsAgainst Cervical Cancer Versus thePromotive Effect of Tobacco Smoking.Healthcare. 2019; 7: 162.

  32. Koshiyama M. The effects of the dietary andnutrient intake on gynecologic cancers.Healthcare 2019; 7: 88.

  33. Zhang X, Dai B, Zhang B, Wang Z. VitaminA and risk of cervical cancer: a metaanalysis. Gynecol Oncol 2012;124(2):366-73.

  34. Shrivastava A, Pradhan S, Mishra SP,Asthana AK, Choudhary S, Zahra K, et al.Serum vitamin A, E and C status in cervicalcancer patients undergoing ConcurrentChemo-Radiotherapy, an institutional study.J Nutr Intermed Metab 2019;18:100107.

  35. Fujii T, Takatsuka N, Nagata C, MatsumotoK, Oki A, Furuta R, et al. Associationbetween carotenoids and outcome ofcervical intraepithelial neoplasia: aprospective cohort study. Int J Clinic Oncol2013;18(6):1091-101.

  36. Muñoz N, Franceschi S, Bosetti C, MorenoV, Herrero R, Smith JS, et al. Role of parityand human papillomavirus in cervicalcancer: the IARC multicentric case-controlstudy. Lancet 2002;359(9312):1093-101.

  37. Brinton LA, Reeves WC, Brenes MM,Herrero R, De BrilTon RC, Gaitan E, et al.Parity as a risk factor for cervical cancer.Ame J Epidemiol 1989;130(3):486-96.

  38. Becker TM, Wheeler CM, McGough NS,Stidley CA, Parmenter CA, Dorin MH, et al.Contraceptive and reproductive risks forcervical dysplasia in southwestern Hispanicand non-Hispanic white women. Int JEpidemiol 1994;23(5):913-22.

  39. Panjaliya R, Dogra V, Gupta S. Study of therisk factors associated with cervical cancer.Biomed Pharmacol J 2015;3(1):179-82.

  40. Brady M. Female genital mutilation:complications and risk of HIV transmission.AIDS Patient Care and STDs1999;13(12):709-16.

  41. Hwang LY, Lieberman JA, Ma Y, Farhat S,Moscicki A-B. Cervical ectopy and theacquisition of human papillomavirus inadolescents and young women. ObstetGynecol 2012;119(6):1164.

  42. Serrano RO, Pérez CJU, Martínez LAD,Romero YRD. Factores de riesgo paracáncer de cuello uterino. Rev Colom ObstetGinecol 2004;55(2):146-60.

  43. Castañeda-Iñiguez MS, Toledo-Cisneros R,Aguilera-Delgadillo M. Factores de riesgopara cáncer cervicouterino en mujeres deZacatecas. Salud Publica Mex 1998;40:330-8.

  44. Liu Z-C, Liu W-D, Liu Y-H, Ye X-H, Chen SD.Multiple sexual partners as a potentialindependent risk factor for cervical cancer: ameta-analysis of epidemiological studies.Asian Pac J Cancer Prev 2015;16(9):3893-900.

  45. Duarte DV, Vieira RC, de Brito EB, PinheiroMdCN, Monteiro JdSV, Valente MDR, et al.Prevalence of human papillomavirusinfection and cervical cancer screeningamong riverside women of the Brazilianamazon. Rev Bras Ginecol Obstet2017;39(07):350-7.

  46. Chan PKS, Chang AR, Cheung JLK, ChanDPC, Xu LY, Tang NLS, et al. Determinantsof cervical human papillomavirus infection:differences between high-and lowoncogenicrisk types. J Infec Dis2002;185(1):28-35.

  47. Wellings K, Collumbien M, Slaymaker E,Singh S, Hodges Z, Patel D, et al. Sexualbehaviour in context: a global perspective.Lancet 2006;368(9548):1706-28.

  48. Nnko S, Boerma JT, Urassa M, Mwaluko G,Zaba B. Secretive females or swaggeringmales?: An assessment of the quality ofsexual partnership reporting in ruralTanzania. Social Sci Med 2004;59(2):299-310.

  49. Lenselink CH, Melchers WJG, Quint WGV,Hoebers AMJ, Hendriks JCM, MassugerLFAG, et al. Sexual behaviour and HPVinfections in 18 to 29 year old women in thepre-vaccine era in the Netherlands. PLoSOne 2008;3(11).

  50. International Collaboration ofEpidemiological Studies of Cervical C.Cervical carcinoma and sexual behavior:collaborative reanalysis of individual data on15,461 women with cervical carcinoma and29,164 women without cervical carcinomafrom 21 epidemiological studies. CancerEpidemiol Biomarkers Prev2009;18(4):1060.

  51. Castellsagué X, Bosch FX, Muñoz N. Themale role in cervical cancer. Salud Pub Mex2003;45:345-53.

  52. Roik E, Sharashova E, Kharkova O, NieboerE, Postoev V, Odland JØ.Sociodemographic characteristics, sexualbehaviour and knowledge about cervicalcancer prevention as risk factors for high-riskhuman papillomavirus infection inArkhangelsk, North-West Russia. Int JCircumpolar Health 2018;77(1):1498681.

  53. Hwang LY, Ma Y, Benningfield SM, ClaytonL, Hanson EN, Jay J, et al. Factors thatinfluence the rate of epithelial maturation inthe cervix in healthy young women. JAdolescent Health 2009;44(2):103-10.

  54. Amorim AT, Marques LM, Campos GB,Lobão TN, de Souza Lino V, Cintra RC, et al.Co-infection of sexually transmittedpathogens and Human Papillomavirus incervical samples of women of Brazil. BMCInfect Dis 2017;17(1):769.

  55. Zhu H, Shen Z, Luo H, Zhang W, Zhu X.Chlamydia trachomatis infection-associatedrisk of cervical cancer: a meta-analysis. Med2016;95(13).

  56. Jensen KE, Thomsen LT, Schmiedel S,Frederiksen K, Norrild B, van den Brule A, etal. Chlamydia trachomatis and risk ofcervical intraepithelial neoplasia grade 3 orworse in women with persistent humanpapillomavirus infection: a cohort study. SexTransm Infect 2014;90(7):550-5.

  57. Alotaibi HJ, Almajhdi FN, Alsaleh AN, ObeidDA, Khayat HH, Al-Muammer TA, et al.Association of Sexually TransmittedInfections and Human Papillomavirus Co-Infection with Abnormal Cervical Cytologyamong Women in Saudi Arabia. Saudi J BiolSci 2020.

  58. de Abreu ALP, Malaguti N, Souza RP,Uchimura NS, Ferreira ÉC, Pereira MW, etal. Association of human papillomavirus,Neisseria gonorrhoeae and Chlamydiatrachomatis co-infections on the risk of highgradesquamous intraepithelial cervicallesion. American journal of cancer research2016;6(6):1371.

  59. Ngoma M, Autier P. Cancer prevention:cervical cancer. Cancer Med Sci 2019;13.

  60. Skorstengaard M, Suhr J, Lynge E. Condomuse to enhance regression of cervicalintraepithelial neoplasia: study protocol for arandomized controlled trial. Trials2019;20(1):473.

  61. Tsai C-C, Wang Y-Y, Chou Y-H, Li C-C, WuW-J. Update on strategies of controllingsexually transmitted infections: Taiwanexperience. Urol Sci 2016;27(3):122-30.

  62. Winer RL, Hughes JP, Feng Q, O'Reilly S,Kiviat NB, Holmes KK, et al. Condom useand the risk of genital human papillomavirusinfection in young women. N Engl J Med2006;354(25):2645-54.

  63. Lam JUH, Rebolj M, Dugué P-A, Bonde J,von Euler-Chelpin M, Lynge E. Condom usein prevention of Human Papillomavirusinfections and cervical neoplasia: systematicreview of longitudinal studies. J Med Screen2014;21(1):38-50.

  64. Cathcart P, Nuttall Mv, Van der Meulen J,Emberton M, Kenny SE. Trends in paediatriccircumcision and its complications inEngland between 1997 and 2003. Brit J Sur2006;93(7):885-90.

  65. Morris BJ, Hankins CA, Banerjee J, LumbersER, Mindel A, Klausner JD, et al. Does MaleCircumcision Reduce Women's Risk ofSexually Transmitted Infections, CervicalCancer, and Associated Conditions? FrontPublic Health 2019;7.

  66. Grund JM, Bryant TS, Jackson I, Curran K,Bock N, Toledo C, et al. Associationbetween male circumcision and women'sbiomedical health outcomes: a systematicreview. Lancet Glob Health2017;5(11):e1113-e22.

  67. Castellsagué X, Bosch FX, Munoz N, MeijerCJLM, Shah KV, De Sanjosé S, et al. Malecircumcision, penile human papillomavirusinfection, and cervical cancer in femalepartners. N Engl J Med 2002;346(15):1105-12.

  68. Svare EI, Kjaer SK, Worm AM, Østerlind A,Meijer C, Van den Brule AJC. Risk factors forgenital HPV DNA in men resemble thosefound in women: a study of male attendeesat a Danish STD clinic. Sex Trans Infect2002;78(3):215-8.

  69. Vaccarella S, Lazcano􀇦Ponce E, Castro􀇦Garduño JA, Cruz􀇦Valdez A, Díaz V,Schiavon R, et al. Prevalence anddeterminants of human papillomavirusinfection in men attending vasectomy clinicsin Mexico. Int J Cancer 2006;119(8):1934-9.

  70. Lajous M, Mueller N, Cruz-Valdéz A, AguilarLV, Franceschi S, Hernández-Ávila M, et al.Determinants of prevalence, acquisition, andpersistence of human papillomavirus inhealthy Mexican military men. CancerEpidemiol Biomarkers Prev2005;14(7):1710-6.

  71. Weiss HA, Thomas SL, Munabi SK, HayesRJ. Male circumcision and risk of syphilis,chancroid, and genital herpes: a systematicreview and meta-analysis. EN2006;82(2):101-10.




2020     |     www.medigraphic.com